2025-524791-30-00Not yet recruitingPhase 1/2
PET imaging For eaRly predictiOn of respoNse to neoadjuvanT tReatment in lUNg caNcER
Source: EU CTIS (euclinicaltrials.eu) · Last updated 14 Oct 2026
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 6 Mar 2026
- Start date
- 1 Aug 2026
- Lead sponsor
- Radboud universitair medisch centrum Stichting
- Diseases
- Lung cancer
- EU CT number
- 2025-524791-30-00
What you commit to
- Study type: Interventional · Phase 1/2
- Planned participants: 40
- 2 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
AI-kivonat: who the study is looking for
Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with non-small cell lung cancer. It studies PET imaging to predict early how people respond to treatment given before surgery.
- Age
- 18 years or older
- Sex
- Women and men can join.
Read by machine on 9 Nov 2026.
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitätsklinikum Tübingen | Tübingen | Germany | Not yet recruiting |
| Radboud universitair medisch centrum Stichting | Nijmegen | Netherlands | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.